Without Concrete Evidence of Potential Infringement Liability, Petitioner Lacked Standing to Challenge PTAB’s Final Written Decision on Appeal

September 16, 2024

Reading Time : 2 min

The Federal Circuit dismissed an appeal from an inter partes review (“IPR”) final written decision for lack of standing where it found the appellant failed to provide evidence sufficient to show it suffered an injury in fact.

The appellant in this case filed an IPR petition challenging the validity of U.S. Patent No. 9,354,369 (“the ’369 Patent”) after the patentee filed two separate suits accusing the appellant’s optical filters of infringement. Ultimately, the PTAB issued a final written decision holding the appellant failed to show the challenged claims were unpatentable. Importantly, while the IPR was pending, the patentee dismissed both of its infringement lawsuits against appellant voluntarily and with prejudice.

The appellant sought review of the PTAB’s final written decision, but was immediately confronted with the threshold question of whether it had standing to appeal. Although a party does not need to establish Article III standing to appear before the PTAB, it must have standing to seek review of a PTAB decision in the Federal Circuit. And to establish standing, the appellant must show, inter alia, that it suffered an injury in fact, i.e., the appellant must allege a harm that is “concrete and particularized” and “actual or imminent, not conjectural or hypothetical.”

Here, the appellant alleged two harms: (1) supplying the filters that were the subject of one of the patentee’s dismissed lawsuits to overseas parties and (2) developing new models of filters. The Federal Circuit considered both grounds and found them insufficient to confer standing.

As to the first harm, the appellant argued it suffered an injury in fact because continuing to distribute its filters, created a likelihood that the patentee once again sue for infringement. As support, the appellant referenced a letter from the patentee stating it did not believe it was possible for the patentee to fulfill its supply agreements with non-infringing products. The court rejected this argument as too speculative because the letter was sent before the patentee filed its prior infringement lawsuits, both of which were dismissed with prejudice.

As to the second ground, the appellant submitted a declaration from its Deputy Director of Operation Management, asserting that it was continuing to develop new filters and it anticipates the patentee will accuse those products of infringement in the future. Here again, the Federal Circuit found the appellant’s alleged harm too speculative. The court noted that appellant’s declaration failed to provide detailed plans for the development of new products, any particulars about those products, or any explanation for how the products might implicate the ’369 Patent. While recognizing that a party need not concede infringement to obtain standing, the Federal Circuit maintained that the appellant’s vague and conclusory statements about future products could not meet the requirement for concrete plans for development. Because the appellant could not meet the requirements for Article III standing, the court dismissed the appeal without reaching the merits of the PTAB’s decision.

Practice Tip: Any party contemplating filing an IPR petition should carefully consider whether it will be able to meet the requirements for standing in any subsequent appeal. In the event there are doubts about standing, the risk of not being able to appeal a final written decision must be weighed against the possible benefits of filing the IPR at that point in time. Ultimately, the decision of whether to file an IPR must balance the risk of no appeal against the relative merits of the IPR and the likelihood that an IPR could be filed in the future among other factors.

Platinum Optics Technology Inc. v. Viavi Solutions Inc., C.A. No. 2023-1227 (Fed. Cir. Aug. 16, 2024).

Share This Insight

Previous Entries

IP Newsflash

March 24, 2025

The Federal Circuit affirmed a Patent Trial and Appeal Board (PTAB) final written decision holding that the prior art exception of AIA Section 102(b)(2)(B) does not apply to a prior sale by an inventor when the sale is conducted in private. According to the Federal Circuit, a sale must disclose the relevant aspects of the invention to the public to qualify for the prior art exception of Section 102(b)(2)(B).

...

Read More

IP Newsflash

March 21, 2025

Under the Lanham Act, a plaintiff who prevails on a trademark infringement claim may be entitled to recover the “defendant’s profits” as damages. The Supreme Court in Dewberry Group, Inc. v. Dewberry Engineers Inc. unanimously construed “defendant’s profits” in 35 USC § 1117(a) to mean that only the named defendant’s profits can be awarded, not the profits of other related corporate entities. The Court, however, left open the possibility that other language in § 1117(a) may allow for damages linked to the profits of related entities, if properly raised and supported.

...

Read More

IP Newsflash

March 13, 2025

In a series of rulings on a motion in limine, the District of Delaware recently distinguished between what qualifies as being incorporated by reference and what does not for the purposes of an anticipation defense. In short, a parenthetical citation was held to be insufficient, while three passages discussing a cited reference met the test.

...

Read More

IP Newsflash

March 4, 2025

On February 28, 2025, the USPTO announced that it was rescinding former Director Vidal’s 2022 memorandum on discretionary denials by the Patent Trial and Appeal Board. The 2022 memorandum effectively narrowed the application of discretionary denials in cases with parallel district court litigation by specifying instances where discretionary denial could not be issued. With the withdrawal of the memorandum, individual PTAB panels will regain flexibility in weighing discretionary denials. While the long-term effect of that increased flexibility is not yet known, the immediate effect is likely to be a shift towards the discretionary analysis applied by PTAB panels before the issuance of the memorandum.

...

Read More

IP Newsflash

March 3, 2025

A District of Delaware judge recently granted a defendant’s motion to include a patent prosecution bar in its proposed protective order after determining that litigation counsel’s ability to practice before the Patent Office—without ever having represented the plaintiffs at the Patent Office in the past—weighed heavily in favor of the bar.

...

Read More

IP Newsflash

February 12, 2025

The Federal Circuit recently reversed a district court decision that found a patent that did not describe after-arising technology failed to satisfy the written description requirement. In so doing, the Federal Circuit explained that written description and enablement are evaluated based on the subject matter that is claimed, not the products that practice those claims. As a result, the patentee was not required to describe unclaimed, later-discovered features of the accused products despite the broad language in the claims that undisputedly covered the products.

...

Read More

IP Newsflash

January 24, 2025

The District of Delaware recently rejected a patentee’s argument that non-production of an opinion letter from counsel, combined with knowledge of the patent, warranted a finding that defendant induced infringement.

...

Read More

IP Newsflash

January 17, 2025

The District of Delaware recently denied a motion to dismiss a patent infringement complaint involving gene editing technology that sought relief under the Safe Harbor Provision of the Hatch-Waxman Act. Specifically, the court found the patentee’s complaint sufficiently alleged at least some uses of the claimed technology that, when taken as true, were not solely uses of a “patented invention” that were “reasonably related” to an FDA submission.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.